We entered into a groundbreaking partnership between The Bardo Foundation, the European Innovation Council (EIC), and Iris.ai to harness the power of artificial intelligence in the fight against osteosarcoma, the most common bone cancer in children.
This innovative project, based at Oslo University Hospital, aims to accelerate research and discoveries by leveraging advanced AI technologies. Iris.ai, renowned for its AI tools in scientific research, will apply its expertise to analyze vast amounts of medical data, identify new treatment pathways, and potentially uncover breakthroughs that can lead to more effective therapies.
Supported by the EIC, this collaboration represents a significant step forward in our mission to bring hope to children and families affected by this challenging condition. By integrating AI into osteosarcoma research, we aim to shorten the time it takes to translate scientific findings into real-world treatments.
Learn more about this initiative in our press release.
We are proud to be at the forefront of this effort and are grateful for the support of our partners. Together, we are pushing the boundaries of what's possible and making strides toward a cure.
Leave a comment